Cargando…
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment
BACKGROUND: The CD4+ T-lymphocytes and their subtype CD4 + CD25(high)FoxP3+ regulatory T cells are receiving growing interest as major regulators of atherogenesis. We sought to investigate 1) whether the CD4 + cell subsets were expressed differently in dyslipidemic patients (Pts) and healthy subject...
Autores principales: | Guasti, Luigina, Maresca, Andrea Maria, Schembri, Laura, Rasini, Emanuela, Dentali, Francesco, Squizzato, Alessandro, Klersy, Catherine, Robustelli Test, Laura, Mongiardi, Christian, Campiotti, Leonardo, Ageno, Walter, Grandi, Anna Maria, Cosentino, Marco, Marino, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731979/ https://www.ncbi.nlm.nih.gov/pubmed/26822994 http://dx.doi.org/10.1186/s12872-016-0201-y |
Ejemplares similares
-
Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients
por: Marino, Franca, et al.
Publicado: (2014) -
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment
por: Marino, Franca, et al.
Publicado: (2012) -
sRAGE and early signs of cardiac target organ damage in mild hypertensives
por: Maresca, Andrea Maria, et al.
Publicado: (2019) -
In vitro effects of Apixaban on 5 different cancer cell lines
por: Guasti, Luigina, et al.
Publicado: (2017) -
Commentary
por: Riva, Nicoletta, et al.
Publicado: (2013)